I now have enough comprehensive content from Harrison's 22e and Robbins Pathology to write a thorough exam-focused overview. Let me compile the answer.
Anaemia - Overview & Classification
Sources: Harrison's Principles of Internal Medicine 22e (2025) | Robbins & Kumar Basic Pathology | Robbins, Cotran & Kumar Pathologic Basis of Disease
Definition
Anaemia is defined as blood counts below the normal range for a given population. In practice:
- Males: Hb < 13.5 g/dL, Hct < 41%
- Females: Hb < 12.0 g/dL, Hct < 37%
Note: In pregnancy, a physiological haemodilution occurs (plasma volume rises ~47%, RBC mass only ~17%), making Hb < 10.5 g/dL and Hct < 33% the threshold for pathological anaemia.
Classification - Two Major Systems
There are two complementary ways to classify anaemia. Knowing both is essential for exams.
1. Morphological Classification (by MCV)
This is the classic Wintrobe classification and the most common starting point in clinical workup.
| Type | MCV | Common Causes |
|---|
| Microcytic | < 80 fL | Iron deficiency, thalassaemia, sideroblastic anaemia, anaemia of chronic disease (sometimes) |
| Normocytic | 80-100 fL | Aplastic anaemia, renal disease, anaemia of inflammation, endocrinopathies, marrow invasion, myeloma, pure red cell aplasia |
| Macrocytic | > 100 fL | Megaloblastic (B12/folate deficiency), liver disease, hypothyroidism, reticulocytosis, alcohol, drugs (hydroxyurea, methotrexate), myelodysplasia |
Key exam point: In iron deficiency, RDW (red cell distribution width) is high (anisocytosis). In thalassaemia, RDW is low/normal (homogeneous microcytes). This distinction is a classic differentiator.
2. Pathophysiological Classification (by Mechanism)
A. Underproduction (Hypoproliferative) - Reticulocyte count LOW
This accounts for at least 75% of all anaemia cases.
| Subcategory | Examples |
|---|
| Nutritional deficiency | Iron, B12, folate, copper, vitamin C |
| Lack of EPO | Chronic renal disease, anaemia of inflammation, anaemia of ageing |
| Absence of red cell precursors | Aplastic anaemia, pure red cell aplasia |
| Stem cell defects | Myelodysplastic syndrome, acute/chronic leukaemia |
| Marrow replacement | Neoplasm (myelophthisic anaemia), granulomas, infections |
B. Increased Destruction / Loss (Hyperproliferative) - Reticulocyte count HIGH
- Blood loss (haemorrhage) - acute or chronic
- Haemolysis - red cell breakdown exceeds marrow output
Haemolytic Anaemias - Classification
| Type | Intrinsic (Corpuscular) | Extrinsic (Extracorpuscular) |
|---|
| Inherited | Hereditary spherocytosis, sickle cell anaemia, thalassaemia, G6PD deficiency | - |
| Acquired | PNH (paroxysmal nocturnal haemoglobinuria) | Autoimmune, mechanical (prosthetic valves), malaria, drugs |
Lab findings in haemolysis: Elevated LDH, low haptoglobin, elevated indirect bilirubin, reticulocytosis, haemoglobinuria (if intravascular).
Key Red Cell Morphology on Peripheral Smear (High-Yield)
| Morphology | Association |
|---|
| Microcytic hypochromic cells | Iron deficiency, thalassaemia |
| Spherocytes | Hereditary spherocytosis, autoimmune haemolytic anaemia |
| Sickle cells | Sickle cell disease |
| Target cells | Thalassaemia, liver disease, HbC |
| Schistocytes (fragmented cells) | Microangiopathic haemolytic anaemia (TTP, DIC, HUS), mechanical valves, burns |
| Macro-ovalocytes + hypersegmented neutrophils | Megaloblastic anaemia (B12/folate deficiency) |
| Teardrop cells (dacrocytes) | Marrow fibrosis (myelofibrosis) |
| Burr cells (echinocytes) | Uraemia |
| Acanthocytes (spur cells) | Liver disease, abetalipoproteinaemia |
| Nucleated RBCs in peripheral blood | Asplenia, severe marrow stress, marrow infiltration |
Red Cell Indices (MCV Table)
| Index | Formula | Normal |
|---|
| MCV | Hct / RBC count × 10 | 85-95 fL |
| MCH | Hb / RBC count × 10 | 27-33 pg |
| MCHC | Hb / Hct × 100 | 33.8-34.2 g/dL |
| RDW | SD of MCV / Mean MCV × 100 | 11.5-14.5% |
Physiological Compensation for Anaemia
The body compensates through three mechanisms (Harrison's 22e):
- Increased cardiac output - oxygen delivery = CO × Hb; occurs within minutes
- Increased 2,3-DPG - shifts O2 dissociation curve right, releasing more O2 to tissues; occurs over hours to days
- Increased plasma volume - preserves BP and cardiac output; occurs over weeks
This explains why chronic anaemia (e.g., thalassaemia, iron deficiency) is often better tolerated than acute anaemia (e.g., haemorrhage).
Clinical Features
| Symptom/Sign | Mechanism |
|---|
| Pallor (conjunctiva, palmar creases) | Reduced Hb |
| Fatigue, lethargy | Tissue hypoxia |
| Dyspnoea on exertion | Compensatory increased CO |
| Resting tachycardia | Compensatory increase in CO |
| Angina / TIA in elderly | Ischaemia due to reduced O2 delivery in atherosclerotic vessels |
| Pica (craving non-food substances) | Iron deficiency specifically |
| Peripheral neuropathy | Vitamin B12 deficiency specifically |
| Jaundice + splenomegaly | Haemolytic anaemia |
| Bone deformities | Severe congenital haemolytic anaemia (marrow hyperplasia) |
Diagnostic Approach (Algorithm)
CBC + Reticulocyte Count
|
_____|_____
| |
Retic HIGH Retic LOW (< 2%)
(Haemolysis/ (Hypoproliferative)
Bleeding) |
| _____|________
Rule out | |
bleeding Low MCV High MCV
| (Microcytic) (Macrocytic)
Haemolysis | |
workup: Ferritin B12/Folate
LDH, haptogl. Low = IDA Smear for
DAT, smear Normal = Thal megaloblasts
(check RDW) Normal MCV = Normocytic
(Renal fn, EPO level,
marrow exam if needed)
Bone Marrow Examination - Indications
Marrow biopsy is indicated when peripheral blood findings suggest:
- Circulating blasts
- Severe pancytopenia
- Very low reticulocyte count (< 0.1%)
- Circulating nucleated RBCs
- Teardrop cells (marrow infiltration)
- Staging lymphoma
- Unexplained severe anaemia
Treatment Principles
| Cause | Treatment |
|---|
| Iron deficiency | Oral ferrous sulphate 60-120 mg elemental iron/day |
| B12 deficiency | IM cyanocobalamin or high-dose oral B12 |
| Folate deficiency | Oral folic acid 1-5 mg/day |
| Anaemia of renal failure | Recombinant EPO + IV iron |
| Aplastic anaemia | Bone marrow transplant / immunosuppression |
| Autoimmune haemolytic anaemia | Corticosteroids, rituximab |
| Blood transfusion | Reserved for Hb-driven haemodynamic compromise, angina, or marrow failure |
References:
- Harrison's Principles of Internal Medicine 22e (2025), Chapter 66 - Harrison's Principles of Internal Medicine 22E
- Robbins & Kumar Basic Pathology, Chapter on Red Cell Disorders - Robbins & Kumar Basic Pathology